These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17877161)

  • 21. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
    Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.
    Bolzoni M; Storti P; Bonomini S; Todoerti K; Guasco D; Toscani D; Agnelli L; Neri A; Rizzoli V; Giuliani N
    Exp Hematol; 2013 Apr; 41(4):387-97.e1. PubMed ID: 23178378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling.
    Kook SH; Son YO; Hwang JM; Kim EM; Lee CB; Jeon YM; Kim JG; Lee JC
    J Cell Biochem; 2009 Apr; 106(6):1010-9. PubMed ID: 19206164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.
    Chamoux E; Houde N; L'Eriger K; Roux S
    J Cell Physiol; 2008 Aug; 216(2):536-42. PubMed ID: 18338379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
    Mori K; Berreur M; Blanchard F; Chevalier C; Guisle-Marsollier I; Masson M; Rédini F; Heymann D
    Oncol Rep; 2007 Dec; 18(6):1365-71. PubMed ID: 17982618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of in vitro growth of multiple myeloma cells.
    Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
    Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
    Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
    Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH
    Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
    Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA
    Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
    Yoshida T; Flegler A; Kozlov A; Stern PH
    J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells.
    Krajewski AC; Biessei J; Kunze M; Maersch S; Perabo L; Noack MJ
    APMIS; 2009 Oct; 117(10):746-54. PubMed ID: 19775343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts].
    Tian QX; Huang GY; Zhou JL; Liu QH; DU XR
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1501-5. PubMed ID: 17785093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of receptor activator of NF-kappa B ligand and osteoprotegerin protein in the giant cell lesions of jaw].
    Meng XM; Yu SF; Wei MJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):294-7. PubMed ID: 16191370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
    Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
    Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.
    Brunetti G; Colucci S; Rizzi R; Mori G; Colaianni G; Oranger A; Zallone A; Liso V; Grano M
    Ann N Y Acad Sci; 2006 Apr; 1068():334-40. PubMed ID: 16831934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.